B3 Sets Up for Next Cycle With Retail Derivatives Push and R$ 3.6 Billion Plan
Exchange says small macro relief could unlock sharp volume gains as it prepares new products for 2026.
Exchange says small macro relief could unlock sharp volume gains as it prepares new products for 2026.
From Azul and Casas Bahia to Cosan and Oncoclínicas, capital restructurings are reshaping ownership as companies trade balance-sheet relief for shareholder dilution.
New regulatory model lets global brokerage offer direct access to Brazilian equities, cutting costs and bureaucracy for individuals abroad.
New derivatives turn Brazil’s “fear index” into a tradable asset for the first time, opening direct access to volatility protection and speculative strategies.
Federal government monetizes stakes in shared pre-salt fields Mero and Atapu; Tupi receives no bids.
Company in court-supervised reorganization cites breakdown in internal controls.
Hospital operator re-enters the R$100bn tier for the first time since early 2021, lifting the big-cap count to an all-time high.
Spanish utility sets a R$32.50 offer price — matching the Previ block — as it seeks to delist Neoenergia from B3’s Novo Mercado.
Forced early maturity of R$433 million in CDBs triggers recovery mechanisms tied to FIP structures holding ONCO3 shares.
Brazil's largest railroad operator saw adjusted EBITDA grow 4.5%, yet net income dropped 39% amid a significant increase in financial costs.
IRB Brasil Re's 3Q25 net income rose, surpassing forecasts. Strong underwriting and financial results drove performance amid a hard reinsurance market.
Light S.A. (LIGT3) posted a 79.3% drop in 3Q25 net profit to R$33 million, impacted by lower temperatures and hydrological conditions.
Description: YDUQS 3Q25 results beat expectations, driven by robust cash flow, premium segment growth, and lower debt. Net revenue rose 3.5% to R$1.35bn.
Hapvida shares plummet over 43% after weak 3Q25 results, prompting the announcement of a new 70 million share buyback program to support the stock.
Vale leads B3’s monthly turnover as Petrobras follows and Equatorial enters the top 10 for the first time in 2025.
Medical loss ratio climbs to 75.2% amid higher service utilization and new hospitals.